Automated Detection of Virus-Specific Antibodies in Cerebrospinal Fluid
Author Information
Author(s): Jörg Schubert, Benedikt Weissbrich
Primary Institution: Institute of Virology and Immunology, University of Würzburg
Hypothesis
Can a fully automated enzyme immunoassay improve the detection of virus-specific IgG in cerebrospinal fluid compared to semi-automated methods?
Conclusion
The automation of virus-specific IgG determination has been successfully implemented, showing good agreement with semi-automated methods.
Supporting Evidence
- The interassay coefficient of variation was below 10% for all parameters tested.
- There was good agreement between AIs obtained with the BEP2000 and AIs derived from the semi-automated reference method.
- The study was approved by the ethics committee of the medical faculty at the University of Würzburg.
Takeaway
This study shows that a machine can help doctors quickly find out if a patient has certain viruses in their spinal fluid, which is important for diagnosing diseases.
Methodology
The study evaluated the precision and diagnostic value of a fully automated enzyme immunoassay for detecting virus-specific IgG in serum and CSF using the BEP2000 analyser.
Limitations
The current version of the analyser software has limited flexibility, requiring manual predilution for samples exceeding the linear range.
Participant Demographics
Included patients with viral CNS infections, multiple sclerosis, and control patients, with a total of 82 samples from various groups.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website